Skip to main content
Equibles

POLYMED · Poly Medicure Limited · Financials

Use POLYMED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research POLYMED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,679.15 INR -14.05 (-0.83%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 3331 Avg daily vol (3M) 8653

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
18.75B +12.3%
FY2026 Revenue FY2020–FY2026
Net Income
3.22B -4.8%
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
2.41B -0.2%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
INR 21.34B 18.75B 16.7B 13.76B 11.15B 9.23B 7.86B 6.87B
INR 1.38B 1.16B 826.36M 639.27M 571.67M 539.52M 475.22M 405.28M
INR 260.18M 182.91M 119.97M 113.01M 88.39M 42.55M 85.12M 183.14M
INR 1.09B 1.07B 1.14B 860.09M 582.09M 487.39M 441.8M 298.45M
INR 3.18B 3.22B 3.39B 2.58B 1.79B 1.47B 1.36B 0
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 1.42B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.